AlphaScreen Identifies MSUT2 Inhibitors for Tauopathy-Targeting Therapeutic Discovery is a research paper published in SLAS DISCOVERY (2020). On theSindex it has a DataRank of 0.304. It has been cited 4 times, with 3 citing works in its 1-hop citation network.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.241
From this paper's citation signal
Citation Network Contribution
0.0630
From 2 citing papers with measurable signal
Ranked by each citer's contribution to N(p) — log1p(Cq) divided by its reference count — out of 3 citers.
National Institutes of Health
Grant: R56AG057642
National Institutes of Health
Grant: RF1AG055474
u.s. department of veterans affairs
Grant: #I01BX002619 and VA PSHCSACOS/R Seed funding
BLRD VA
Grant: I01 BX002619
National Institutes of Health
Grant: 5I01BX002619-02
Identifying new tau targeted therapeutics: a drug repurposing approach
National Institutes of Health
Grant: 1RF1AG055474-01
MSUT2 modulates pathological tau in AD and model organisms
National Institutes of Health
Grant: 1R56AG057642-01A1
Reversing tauopathy by inhibiting MSUT2 RNA-binding activity
washington research foundation
FWCI
0.15
Citation Percentile
0.5%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals